ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

VLG Venture Life Group Plc

39.50
-0.50 (-1.25%)
21 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Venture Life Group Plc LSE:VLG London Ordinary Share GB00BFPM8908 ORD 0.3P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.50 -1.25% 39.50 39.00 40.00 40.00 39.50 40.00 92,367 12:21:57
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Misc Retail Stores, Nec 43.98M 520k 0.0041 96.34 49.7M
Venture Life Group Plc is listed in the Misc Retail Stores sector of the London Stock Exchange with ticker VLG. The last closing price for Venture Life was 40p. Over the last year, Venture Life shares have traded in a share price range of 27.00p to 42.50p.

Venture Life currently has 125,831,530 shares in issue. The market capitalisation of Venture Life is £49.70 million. Venture Life has a price to earnings ratio (PE ratio) of 96.34.

Venture Life Share Discussion Threads

Showing 19826 to 19848 of 36725 messages
Chat Pages: Latest  797  796  795  794  793  792  791  790  789  788  787  786  Older
DateSubjectAuthorDiscuss
12/7/2018
12:37
Then again there's only so many you can hold I suppose
panic investor
12/7/2018
12:37
Apad, somewhat surprised you don't hold ACSO or NMC for that matter
panic investor
12/7/2018
11:28
APAD, wise words about not punishing winners.
The ZOO rise seems relentless and I'm obviously now regretting having sold some!
Bought some more back just over 100p and have a very decent holding size but...

homebrewruss
12/7/2018
10:56
BVXP - a couple of weeks old from Journal of Clinical Chemistry looking at clinical performance of Siemens hsTnI. Conclusion: "Diagnostic accuracy and clinical utility of the novel Siemens-hs-cTnI-Centaur assay are high and comparable with the established hs-cTn assays" Not a surprise. Adds to the smoke suggesting FDA approval for Siemens troponin may not be far away.
gsbmba99
12/7/2018
10:27
Your ARC was up about 50% last year,j.

That holding now up about 150%.

Don't punish winners - I think I'll get a tattoo.

apad😎

apad
12/7/2018
10:00
but only 1 last year I recall apad!
janeann
12/7/2018
09:59
ARC in four of the Comparison entries.

XAAR joint venture in high speed 3D sintering. Too late folks.

apad

apad
12/7/2018
09:31
....and apad's daughter.

apad himself took profits! Idiot.

ABC could be heading for a BTFD opportunity between now and the Sept. results. Fairly typical pattern.
I am looking for their current capital spend on software and offices to die down.

ASOS slipped - so very big now.
I suspect the weather will act in BOO's skimpy frocks favour.

apad
12/7/2018
09:19
Certainly am multi. gone beyond current expectations. Tempted to topslice.

But then 'run ones winners and punish loosers# says apad.

What to do with THAL is my problem? still have a large holding ad somewhat underwater. Hit by oil price collapse back in 2015. should have sold immediately. Didn't!

janeann
12/7/2018
09:04
ARC powering ahead - has added about 34.5p to share price since trading update two days ago. Now 112p on bid - surely can't go on at this rate and a retrace due ?

Janeann, Cbootle and I - mega delighted I would expect :)

multibagger
12/7/2018
08:48
😊
ABC growing above market rate and custom products growing very well.
Typically pragmatic language.

OPTI large director purchase.

apad

apad
12/7/2018
08:40
Looks like Hill & Smith barriers have been erected around the US Ambassador's residence.
Trump's visit good news for some:-)

red

redartbmud
12/7/2018
08:18
Recent quarterly AuM updates from comparison holdings PAM and LIO. LIO AuM grew from £10.475bn as at 31 Mar to £11.424bn as at 30 Jun. Net inflows of £320m and market performance of £629m. YoY AuM growth of 23.5%. PAM AuM grew from £6.365bn at 31 Mar to £6.773bn at 30 Jun. Net inflows of £202m and market performance of £205.6m. YoY AuM growth of 15.9%.
gsbmba99
11/7/2018
22:10
These are my core holdings, in order.
FEVR
BOO
ABC
BVXP
RSW
TSTL
SPX
AMS
HLMA
PRV
PTSG
DOTD
FFX
QTX
VCT
Then there are puppies.

apad
11/7/2018
22:08
It just grew that way, j, when I decided that top-slicing was punishing success.
I wouldn't describe my feeling as confidence though.
When it goes wrong (FARN) it is shocking.
I am not dependent on my portfolio for a living - makes a difference.
Couldn't agree more about dross - punish failure.
apad😎

apad
11/7/2018
20:58
That's a pretty focussed pf apad. Im about 68% in 9 shares including about 8% cash. Largest acso a mere 13%! Perhaps time builds confidence al;though it helps with the massive rise in a stock like fevr. The message I get from that is I downsize too much (and certainly far too much with prsm)! (and too much dross that I should get rid of!)

thanks

janeann
11/7/2018
20:54
"Anderson didn’t comment on Musk specifically or elaborate on Tesla’s issues while speaking from Allen & Co.’s Sun Valley conference. The electric-car maker’s chief executive officer has made headlines by attacking journalists and Wall Street analysts in recent months as the company has struggled to ramp up production of its Model 3 sedan and stem losses.

Baillie Gifford owned 12.8 million shares as of the end of March, a stake that’s worth more than $4 billion at current prices.

Only Musk, T. Rowe Price and Fidelity owner FMR LLC have a bigger position, according to data compiled by Bloomberg."

12.8 million shares in an article of faith! Odds Bodikins.

apad😎

apad
11/7/2018
20:35
Brooklyn is where FEVR is in yoodleland.

www.wrcbtv.com/story/38522712/fever-tree-the-worlds-leading-premium-mixer-brand-launches-pink-aromatic-tonic-july-2018

apad

apad
11/7/2018
16:42
Top six shares now 78% of portfolio, j.
FEVR
BOO
ABC
BVXP
RSW
TSTL

and FEVR is 32%.

Gulp

Coke-Pepsi wars are back:
money.cnn.com/2018/04/26/news/companies/pepsi-earnings-coca-cola/index.html
and this is where FEVR's Madagascan Cola will be trying to make its mark.

apad

apad
11/7/2018
15:42
Thanks chootle, insightful overview of Avast prospects
attrader
11/7/2018
15:31
well I have been pretty impressed at the recent rise in acso but I watch in sheer amazement at the ever rising fevr - as it breaks into new ground again and again - and what is it - just another mixer I thought! Well done for continuing to hold apad;
janeann
11/7/2018
12:45
Can't see any expansion for Avast. They were and are one of the biggest providers of free anti-virus (relying on "upgrades"). Some 10 - 15 years ago the two biggies in this field were Avast! and AVG, with AVG being the better known at least in the UK. But that's a shrinking market as fewer and fewer people use laptops for home use. Corporations use enterprise quality anti-virus (e.g. Symnantec), and there would be a high barrier to entry for Avast. Avast bought AVG in 2016.

My gut feeling (and it's only a gut feeling) is that their current business model is no longer working so they are looking to raise money as an act of desperation (having spent loads on buying out their biggest competitor).

A recent round up review of anti-virus: hxxps://www.techradar.com/news/the-best-free-antivirus

In short, why do they need the money and why did they not have an IPO in the good days when they were riding high? IMO avoid, but gamblers might like to place a punt on an initial rise (and fall) due to brand awareness giving some excitement.

cbootle
11/7/2018
12:06
Has anyone looked into Avast ? New IPO offering security scanning software ..
attrader
Chat Pages: Latest  797  796  795  794  793  792  791  790  789  788  787  786  Older

Your Recent History

Delayed Upgrade Clock